Brentuximab vedotin

Por van de Donk, Niels W. C.J., Dhimolea, Eugen
Publicado em 2012

How I treat plasma cell leukemia

Por van de Donk, Niels W. C. J., Lokhorst, Henk M., Anderson, Kenneth C., Richardson, Paul G.
Publicado em 2012

Primary cardiac lymphoma with central nervous system relapse

Por van Rooijen, Cleo R., Scholtens, Asbjorn M., de Jong, C. Niels, Saraber, Colette E., van de Donk, Niels W. C. J.
Publicado no Clin Case Rep (2017)

Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma

Por Schmitz, Marian F., Otten, Henny G., Franssen, Laurens E., van Dorp, Suzanne, Strooisma, Theo, Lokhorst, Henk M., van de Donk, Niels W.C.J.
Publicado no Haematologica (2014)

Monoclonal antibodies targeting CD38 in hematological malignancies and beyond

Por van de Donk, Niels W. C. J., Janmaat, Maarten L., Mutis, Tuna, Lammerts van Bueren, Jeroen J., Ahmadi, Tahamtan, Sasser, A. Kate, Lokhorst, Henk M., Parren, Paul W. H. I.
Publicado no Immunol Rev (2016)

Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomide

Por Nijhof, Inger S., van Bueren, Jeroen J. Lammerts, van Kessel, Berris, Andre, Pascale, Morel, Yannis, Lokhorst, Henk M., van de Donk, Niels W.C.J., Parren, Paul W.H.I., Mutis, Tuna
Publicado no Haematologica (2015)

Daratumumab depletes CD38(+) immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma

Por Krejcik, Jakub, Casneuf, Tineke, Nijhof, Inger S., Verbist, Bie, Bald, Jaime, Plesner, Torben, Syed, Khaja, Liu, Kevin, van de Donk, Niels W. C. J., Weiss, Brendan M., Ahmadi, Tahamtan, Lokhorst, Henk M., Mutis, Tuna, Sasser, A. Kate
Publicado no Blood (2016)

A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization

Por Drent, Esther, Themeli, Maria, Poels, Renée, de Jong-Korlaar, Regina, Yuan, Huipin, de Bruijn, Joost, Martens, Anton C.M., Zweegman, Sonja, van de Donk, Niels W.C.J., Groen, Richard W.J., Lokhorst, Henk M., Mutis, Tuna
Publicado no Mol Ther (2017)

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network

Por van de Donk, Niels W.C.J., Palumbo, Antonio, Johnsen, Hans Erik, Engelhardt, Monika, Gay, Francesca, Gregersen, Henrik, Hajek, Roman, Kleber, Martina, Ludwig, Heinz, Morgan, Gareth, Musto, Pellegrino, Plesner, Torben, Sezer, Orhan, Terpos, Evangelos, Waage, Anders, Zweegman, Sonja, Einsele, Hermann, Sonneveld, Pieter, Lokhorst, Henk M.
Publicado em 2014

Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance

Por de Haart, Sanne J., Holthof, Lisa, Noort, Willy A., Minnema, Monique C., Emmelot, Maarten E., Aarts-Riemens, Tineke, Doshi, Parul, Sasser, Kate, Yuan, Huipin, de Bruijn, Joost, Martens, Anton C.M., van de Donk, Niels W.C.J, Lokhorst, Henk M., Groen, Richard W.J., Mutis, Tuna
Publicado no Haematologica (2016)

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma

Por Drent, Esther, Groen, Richard W.J., Noort, Willy A., Themeli, Maria, Lammerts van Bueren, Jeroen J., Parren, Paul W.H.I., Kuball, Jürgen, Sebestyen, Zsolt, Yuan, Huipin, de Bruijn, Joost, van de Donk, Niels W.C.J., Martens, Anton C.M., Lokhorst, Henk M., Mutis, Tuna
Publicado no Haematologica (2016)

European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

Por Terpos, Evangelos, Kleber, Martina, Engelhardt, Monika, Zweegman, Sonja, Gay, Francesca, Kastritis, Efstathios, van de Donk, Niels W.C.J., Bruno, Benedetto, Sezer, Orhan, Broijl, Annemiek, Bringhen, Sara, Beksac, Meral, Larocca, Alessandra, Hajek, Roman, Musto, Pellegrino, Johnsen, Hans Erik, Morabito, Fortunato, Ludwig, Heinz, Cavo, Michele, Einsele, Hermann, Sonneveld, Pieter, Dimopoulos, Meletios A., Palumbo, Antonio
Publicado no Haematologica (2015)

Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

Por Sonneveld, Pieter, Avet-Loiseau, Hervé, Lonial, Sagar, Usmani, Saad, Siegel, David, Anderson, Kenneth C., Chng, Wee-Joo, Moreau, Philippe, Attal, Michel, Kyle, Robert A., Caers, Jo, Hillengass, Jens, San Miguel, Jesús, van de Donk, Niels W. C. J., Einsele, Hermann, Bladé, Joan, Durie, Brian G. M., Goldschmidt, Hartmut, Mateos, María-Victoria, Palumbo, Antonio, Orlowski, Robert
Publicado no Blood (2016)

High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignanc...

Por Cook, Gordon, Iacobelli, Simona, van Biezen, Anja, Ziagkos, Dimitris, LeBlond, Veronique, Abraham, Julie, McQuaker, Grant, Schoenland, Stefan, Rambaldi, Alessandro, Halaburda, Kazimierz, Rovira, Maria, Sica, Simona, Byrne, Jenny, Sanz, Ramon Garcia, Nagler, Arnon, van de Donk, Niels W.C.J., Sinisalo, Marjatta, Cook, Mark, Kröger, Nicolaus, De Witte, Theo, Morris, Curly, Garderet, Laurant
Publicado no Haematologica (2017)